Search research articles
Contact Us
Filters
Showing results (91-100 of 217) with videos related to
Page
of 22
Sort By:
Nature Communications
|
June 4, 2024
Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group
Gilles Freyer, Anne Floquet, Olivier Tredan, et al.
Cancers
|
March 21, 2020
Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer
Paul Kubelac, Catherine Genestie, Aurelie Auguste, et al.
British Journal of Cancer
|
December 18, 2019
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
Catherine Genestie, Félix Blanc-Durand, Aurélie Auguste, et al.
Gynecologic Oncology
|
September 12, 2022
Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review
Eric Pujade-Lauraine, David S P Tan, Alexandra Leary, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2023
Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours
Alexandra Leary, Ana Oaknin, José Manuel Trigo, et al.
Human Pathology
|
April 30, 2024
Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis
Carine Ngo, Sophie Cotteret, Imène Deneche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2019
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
Olivier Colomban, Michel Tod, Alexandra Leary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2019
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Hyun Cheol Chung, Willeke Ros, Jean-Pierre Delord, et al.
Nature Communications
|
February 20, 2025
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial
Max Piffoux, Alexandra Leary, Philippe Follana, et al.
The Oncologist
|
February 9, 2017
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment
Pierre Annede, Sébastien Gouy, Renaud Mazeron, et al.
Page
of 22
Search research articles
Search
Showing results (91-100 of 217) with videos related to
Sort By:
Page
of 22
Nature Communications
|
June 4, 2024
Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group
Gilles Freyer, Anne Floquet, Olivier Tredan, et al.
Cancers
|
March 21, 2020
Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer
Paul Kubelac, Catherine Genestie, Aurelie Auguste, et al.
British Journal of Cancer
|
December 18, 2019
Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
Catherine Genestie, Félix Blanc-Durand, Aurélie Auguste, et al.
Gynecologic Oncology
|
September 12, 2022
Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review
Eric Pujade-Lauraine, David S P Tan, Alexandra Leary, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 27, 2023
Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours
Alexandra Leary, Ana Oaknin, José Manuel Trigo, et al.
Human Pathology
|
April 30, 2024
Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis
Carine Ngo, Sophie Cotteret, Imène Deneche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2019
Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study
Olivier Colomban, Michel Tod, Alexandra Leary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2019
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Hyun Cheol Chung, Willeke Ros, Jean-Pierre Delord, et al.
Nature Communications
|
February 20, 2025
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial
Max Piffoux, Alexandra Leary, Philippe Follana, et al.
The Oncologist
|
February 9, 2017
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment
Pierre Annede, Sébastien Gouy, Renaud Mazeron, et al.
Page
of 22